God is still using those who are ready to be used. 'Cancer' is a terminal disease that has claimed the lives of many. This new discovery will save the life of so many too. It goes to show that there is a solution to every problem out there and that if only men will tap into their gifts the world can be a better place.
I am so excited to see that some people are focused on using their gifts to help humanity. We all are created for this purpose. There is certainly something you and I can do to make a difference. Have you ever thought of what your gift might be? I just want to encourage you that the seed of greatness inside of you is waiting to burst and disperse all over the world bearing much fruit. Be encouraged as you read this article and pray for God to open the eyes of your understanding and give you more clarity for the journey ahead.
I am so excited to see that some people are focused on using their gifts to help humanity. We all are created for this purpose. There is certainly something you and I can do to make a difference. Have you ever thought of what your gift might be? I just want to encourage you that the seed of greatness inside of you is waiting to burst and disperse all over the world bearing much fruit. Be encouraged as you read this article and pray for God to open the eyes of your understanding and give you more clarity for the journey ahead.
Hope for terminal cancer patients as new trial of tumour-destroying vaccine starts in the UK
- Vaccine designed to make body's immune system destroy cancer cells
- Immunotherapy trial in London and Guildford follows success in the US
- Patient Kelly Potter, 35, says trial has 'changed her life for the better'
A woman with advanced cervical cancer has become one of the first people in the UK to trial a new vaccine designed to stimulate the body's immune system into destroying tumours.
Kelly Potter, 35, was diagnosed in July and told the cancer was already at stage four.
She is now one of 30 patients in the immunotherapy trial which will examine whether a vaccine is effective in encouraging the immune system to destroy cancer cells.
The treatment - for people with solid tumours and those who have failed on previous types of cancer treatment - is being tested in Guildford and London and expected to run for up to two years.
The immunotherapy trial will examine whether a vaccine is effective in stimulating the body's own immune system to destroy cancer cells with the trial expected to run for up to two years
Immunotherapy is generating great interest in the cancer research community. In February, experts in the US announced they had seen 'extraordinary' results in early trials involving terminally ill patients with blood cancer.
All patients with any solid tumour, irrespective of their type of cancer, are believed to have the potential to benefit from immunotherapy.
Miss Potter, from Beckenham, had her first injection on February 9 and is scheduled for a further seven visits.
'Although I had excellent treatment at Guy's Hospital where the cancer was stabilised, it had already spread to spots on my liver and lungs,' she said.
'So when I was told that I may be eligible for this trial, I was delighted.'
The new Vaper trial involves a vaccine and an immunity stimulating cream applied to the injection site to help the vaccine work better.
Patients will also take low-dose chemotherapy tablets and some people will also have celecoxib, which is a non-steroidal anti-inflammatory.
Professor Hardev Pandha, who is leading the trial at the Surrey Cancer Research Institute, said: 'We know that the immune system in patients with advanced cancer is suppressed, so it's unable to recognise and kill cancer calls.
'In this trial we are investigating a form of immunotherapy designed to activate the body's immune system by administration of a vaccine based on fragments of a key cancer protein.'
The vaccine is designed to treat terminal cancer by making the body's immune system attack the cells
Life sciences minister George Freeman said the trial was 'pushing new boundaries' and brought hope to cancer patients.
'The prospect of a vaccine to help the body's immune system fight advanced cancer highlights the ground-breaking work being delivered by our world-leading life sciences sector, supported through the Government's continued investment in the National Institute for Health Research,' he said.
Miss Potter said she hoped the trial would result in a major breakthrough for patients like herself.
'To be part of the trial has changed my life for the better,' she said.
'It's been a very positive experience and really interesting. I feel honoured to be involved.
'My hope for the future is to beat the cancer for as long as I can and, if I can't, I have come to terms with that.
'I would like to go on and inspire others with cancer.'
Professor Peter Johnson, Cancer Research UK's chief clinician, said: 'Treatments such as the one being tested in this study may be able to direct the immune system to mistakes in our cells which turn them into cancer.
'For this target, we hope that the combination of vaccine and immune boosting treatment will be more effective than the vaccine has been previously on its own.
'For many patients in this trial, all their other options will have been explored so it's vital we continue to explore different ways to treat the disease.'
No comments:
Post a Comment